Spending power
TheGrid Corporate Spending Power index would rate purchasing capacity from registry, scale and activity signals.
Spending power
Key facts
Counted staff
37
self-reported 11–50 band
Founded
2001
25 years
Legal entities
1
ABR
Office countries
1
1 address
Funding rounds
4
Post IPO equity · May 2025 · US$ 2.9M
Company type
Public Company
self-reported
Legal entity
1 brand → 1 confirmed entity
PROTEOMICS INTERNATIONAL PTY LTD
ABN78096013455
Legal entities
Show as table · Proteomics International: 1 registry entity
| PROTEOMICS INTERNATIONAL PTY LTD | ABN 78096013455 |
|---|---|
| Confirmed matches | 0 of 1 |
A candidate is a name match on the registry, not a confirmed identity, and two candidates are ambiguity rather than a corporate structure.
Description
Proteomics International Laboratories Limited (ASX:PIQ) is a medical technology company at the forefront of predictive diagnostics and bio-analytical services. The Company specialises in the area of proteomics – the industrial scale study of the structure and function of proteins. Proteomics International's mission is to improve the quality of lives by the creation and application of innovative tools that enable the improved treatment of disease.
To learn more please visit: www.proteomics.com.au/
Specialties
All 19 specialties
- In-Vitro Diagnostics
- Predictive Diagnostics
- Medical Prognostics
- Platform Technology
- Proprietary Algorithm
- Proteomics
- Diabetes Management
- Diabetic Kidney Disease (DKD)
- Asymptomatic Disease
- Personalised Medicine
- Precision Therapy
- ELISA Test
- Biosimilars / Biologics Drug Characterisation
- Biomarker Discovery
- Drug Discovery
- Pharmacokinetic Testing
- Proteome Mapping
- Accredited Protein Analytical Services
- HPLC-MS
Locations
Country footprint
Show as table · Offices in 1 country
| Countries | 1 |
|---|---|
| Primary country | AU |
All codes: AU
Addresses
- AUPO BOX 3008 Broadway; Nedlands; Perth, Western Australia 6009Primary
Grid intelligence Members
Funding
Last round · 22 May 2025US$ 2.9MPost IPO equity
Rounds4
Round typePost IPO equity · secondary transaction
Amount (USD)2,900,000
Stage rank6
Investors named0
Since last round8 mo
Funding
Show as table · 4 funding rounds
| Rounds | 4 |
|---|---|
| Axis | 2001 to 2026 |
| Post IPO equity · 22 May 2025 | US$ 2.9M |
Dated rounds only. The axis ends at the date this profile was last observed, not at today.
Signals & hiring
Hiring, headcount and registry-change signals, streamed to members.
Latest signal
Hiring activity
Headcount trend
Financials
Registry-filed capital and financial indicators, standardised by TheGrid.
Paid-up capital
Fiscal period
Registered charges
Revenue
Profit / loss
People & contacts
4 employee profiles on record · names withheld.
Names and titles are intentionally absent from this page. The source relation carries no consent record across the privacy regimes this directory spans, so it is never requested and never stored. Search engines see exactly what you see here.
The people relation is never requested, so there is nothing here to unlock.
FAQ
Which legal entity operates under Proteomics International?
One Western Australia entity on the ABR: PROTEOMICS INTERNATIONAL PTY LTD (ABN 78 096 013 455), high confidence.
How many people work at Proteomics International?
37 counted staff profiles at January 2026, inside the self-reported 11–50 band.
Where does Proteomics International have offices?
One address on record, Australia only. Primary: PO BOX 3008 Broadway, Nedlands, Perth, Western Australia 6009.
Has Proteomics International raised funding?
Four rounds. Latest 22 May 2025: post IPO equity, US$2,900,000.
What does Proteomics International list as its specialties?
19 tags on the brand's own list, among them diabetes management.
Which companies are listed alongside Proteomics International?
22 profiles list Proteomics International as a peer — 97th percentile in Medical Device. It lists ten peers of its own. Resonance Health Ltd and Lixa list it back.